Molecular image-guided surgery in gynaecological cancer: where do we stand?

Giusi Pisano1, Thomas Wendler2,3, Renato A Valdés Olmos4

  • 1Section of Nuclear Medicine, University Department of Radiological Sciences and Haematology, Università Cattolica del Sacro Cuore, Rome, Italy.

Abstract

Insights

Molecular image-guided surgery enhances gynaecological cancer treatment. Innovations like hybrid imaging and robotic systems offer precise, personalized, and minimally invasive surgical options.

Area of Science:

  • Oncology
  • Surgical Innovation
  • Medical Imaging

Background:

  • Molecular image-guided surgery is advancing rapidly in gynaecological oncology.
  • Current technologies offer new possibilities for surgical planning and execution.

Purpose of the Study:

  • To review the current clinical and technological status of molecular image-guided surgery in gynaecological malignancies.
  • To highlight key applications and emerging trends in the field.

Main Methods:

  • A narrative review of relevant literature was conducted.
  • Focus on clinical applications, preoperative imaging for surgical roadmapping, and intraoperative devices.

Main Results:

  • Sentinel node biopsy (SNB) is the most common application.
  • Other promising techniques include receptor-target modalities and occult lesion localization.
  • Preoperative SPECT/CT and PET/CT aid surgical planning; intraoperative tools range from probes to 3D imaging.

Conclusions:

  • Innovation is shifting towards hybrid modalities (e.g., SPECT/CT, PET/CT) and advanced tracers.
  • Robotic surgery, augmented reality (AR), and virtual reality (VR) are integrating into clinical practice.
  • These technologies enable precise, personalized, and minimally invasive surgery for gynaecological cancers.

Related Concept Videos